SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Sequenom, Inc. today announced that it will release second quarter 2006 financial results on August 3, 2006 before market open. Company management will host an investment community conference call beginning at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) on Thursday, August 3, 2006 to discuss financial results, provide a business update and answer questions.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO )
To participate in the live call by telephone, please dial (866) 844-2998 from the U.S., and for international callers, please dial (706) 643-9669. A telephone replay will be available for 48 hours by dialing (800) 642-1687 from the U.S., or (706) 645-9291 for international callers, and entering reservation number 3769563.
Individuals interested in listening to the conference call via the Internet may do so by visiting www.sequenom.com. A replay will be available on the Company’s Web site for 30 days.
About Sequenom
Sequenom is committed to providing the best genetic analysis products that translate genomic science into superior solutions for non-invasive prenatal testing, biomedical research, molecular medicine and agricultural applications. The Company’s proprietary MassARRAY(R) system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. The Company has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY(R) system and other platforms.
Sequenom(R) and MassARRAY(R) are trademarks of Sequenom, Inc.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comSequenom, Inc.
CONTACT: John Sharp, Principal Financial Officer of Sequenom, Inc.,+1-858-202-9032; or Investor Relations, Zachary Bryant, zbryant@lhai.com,or Jody Cain, jcain@lhai.com, both of Lippert/Heilshorn & Associates,+1-310-691-7100, for Sequenom, Inc.
Web site: http://www.sequenom.com//
